Cargando...
Contemporary Treatment of Metastatic Renal Cell Carcinoma
The introduction of targeted therapy has revolutionized the treatment of patients with metastatic renal cell carcinoma (mRCC). The current standard of care focuses on the inhibition of angiogenesis through the targeting of the vascular endothelial growth factor receptor (VEGFR) and the mammalian tar...
Guardado en:
| Publicado en: | Oncol Rev |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
PAGEPress Publications, Pavia, Italy
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4943094/ https://ncbi.nlm.nih.gov/pubmed/27471582 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/oncol.2016.295 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|